Monday 26 December 2011

Metapyrin




Metapyrin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Metapyrin



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Metapyrin in the following countries:


  • Germany

International Drug Name Search

Friday 23 December 2011

Azelnidipine




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0123524-52-7

Chemical Formula

C33-H34-N4-O6

Molecular Weight

582

Therapeutic Category

Antihypertensive, calcium channel blocker

Chemical Names

(+-)-3-(1-diphenylmethylazetidin-3-yl) 5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate

2-Amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-[1-(diphenylmethyl)-3-azetidinyl] 5-(1-methylethyl) ester

3-[1-(Diphenylmethyl)-3-azetidinyl] 5-isopropyl (+-)-2-amino-1,4-dihydro-6-methyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate (WHO)

Foreign Names

  • Azelnidipinum (Latin)
  • Azelnidipin (German)
  • Azelnidipine (French)
  • Azelnidipino (Spanish)

Generic Names

  • Azelnidipine (OS: JAN)
  • CS-905 (IS)
  • GJ0956 (IS)
  • RS-9054 (IS)
  • UNII-PV23P19YUG (IS)

Brand Name

  • Calblock
    Daiichi Sankyo, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 22 December 2011

Pentobarbital




In some countries, this medicine may only be approved for veterinary use.


In the US, Pentobarbital (pentobarbital systemic) is a member of the drug class barbiturates and is used to treat Insomnia and Sedation.

US matches:

  • Pentobarbital

  • Pentobarbital Sodium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CA01

CAS registry number (Chemical Abstracts Service)

0000076-74-4

Chemical Formula

C11-H18-N2-O3

Molecular Weight

226

Therapeutic Categories

Antiepileptic agent

Agent for premedication

Hypnotic and sedative agent

Chemical Name

2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-

Foreign Names

  • Pentobarbitalum (Latin)
  • Pentobarbital (German)
  • Pentobarbital (French)
  • Pentobarbital (Spanish)

Generic Names

  • Pentobarbital (OS: BAN, DCIT, DCF)
  • Acidum aethylmethylbutylbarbituricum (IS)
  • Ethaminal (IS)
  • Mebubarbital (IS)
  • Mebumalum (IS)
  • Pentobarbitone (IS)
  • Pentobarbital (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Pentobarbitalum (PH: Ph. Eur. 6)
  • Pentobarbital Sodium (OS: JAN, BANM)
  • Barbityral (IS)
  • Natrium aethyl-methylbutylbarbituricum (IS)
  • Pentobarbitone Sodium (IS)
  • Pentobarbitone, soluble (IS)
  • Pentobarbital sodique (PH: Ph. Eur. 6)
  • Pentobarbital Sodium (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Pentobarbital-Natrium (PH: Ph. Eur. 6)
  • Pentobarbitalum natricum (PH: Ph. Eur. 6)

Brand Names

  • Mebumal SAD
    Amgros, Denmark


  • Narkodorm (veterinary use)
    CP-Pharma, Germany


  • Nembutal
    Dainippon Sumitomo, Japan


  • Ravona
    Tanabe Mitsubishi, Japan


  • Sagatal (veterinary use)
    Merial, Ireland


  • Beuthanasia D (Pentobarbital and Phenytoin (veterinary use))
    Schering-Plough Animal Health, United States


  • Combuthal (Pentobarbital and Thiopental Sodium (veterinary use))
    Cross Vetpharm, United States


  • Dolethal (veterinary use)
    Vetoquinol, Belgium; Vetoquinol, United Kingdom; Vetoquinol, Ireland; Vetoquinol, Netherlands


  • Doléthal (veterinary use)
    Laboratoire Vétoquinol, France


  • Dorminal (veterinary use)
    Alfasan, Netherlands; Alfasan International, Poland


  • Esconarkon (veterinary use)
    Streuli Vet, Switzerland


  • Eutasil (veterinary use)
    Ceva, Portugal


  • Eutha Naze (veterinary use)
    Bayer Animal Health, South Africa


  • Eutha (veterinary use)
    Essex Tierarzneimittel, Germany; Veterinaria, Switzerland


  • Euthal (Pentobarbital and Phenytoin (veterinary use))
    Delvet, Australia


  • Euthanasia III (Pentobarbital and Phenytoin (veterinary use))
    Med Pharmex, United States


  • Euthasol (Pentobarbital and Phenytoin (veterinary use))
    Virbac, United States


  • Euthasol (veterinary use)
    A.S.T. farma B.V, Netherlands


  • Euthatal (veterinary use)
    Merial, United Kingdom; Merial, Ireland


  • Euthesate (veterinary use)
    Ceva, Netherlands


  • Lethabarb (veterinary use)
    Virbac, Australia


  • Lethanal (veterinary use)
    Eurovet, Netherlands


  • Lethobarb (veterinary use)
    Fort Dodge, United Kingdom


  • Mebunat (veterinary use)
    Orion, Finland


  • Narcoren (veterinary use)
    Merial, Germany


  • Natriumpentobarbital (veterinary use)
    Kela, Belgium


  • Nembutal Sodium
    Lundbeck, United States


  • Nembutal
    Lundbeck, United States


  • Nembutal (veterinary use)
    Ceva, Belgium; Ceva, Netherlands


  • Pentobarb (veterinary use)
    Ilium Veterinary Products, Australia; Provet, New Zealand


  • Pentobarbital (veterinary use)
    Ceva, France; Loveridge, United Kingdom


  • Pentobarbitone (veterinary use)
    Ilium Veterinary Products, Australia


  • Pentoject (veterinary use)
    Animalcare, United Kingdom


  • Release (veterinary use)
    WDT, Germany


  • Sagatal (veterinary use)
    Merial, United Kingdom


  • Somnopentyl (veterinary use)
    Schering-Plough Animal Health, United States


  • Valabarb (veterinary use)
    Jurox, Australia

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Targinact




Targinact may be available in the countries listed below.


UK matches:

  • Targinact 5 mg/2.5 mg, 10 mg/5 mg, 20 mg/10 mg and 40 mg/20 mg prolonged-release tablets

Ingredient matches for Targinact



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Targinact in the following countries:


  • United Kingdom

Oxycodone

Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of Targinact in the following countries:


  • United Kingdom

International Drug Name Search

Wednesday 21 December 2011

Fusitop




Fusitop may be available in the countries listed below.


Ingredient matches for Fusitop



Fusidic Acid

Fusidic Acid is reported as an ingredient of Fusitop in the following countries:


  • Argentina

International Drug Name Search

Sunday 18 December 2011

Moldine




Moldine may be available in the countries listed below.


Ingredient matches for Moldine



Bifonazole

Bifonazole is reported as an ingredient of Moldine in the following countries:


  • Japan

International Drug Name Search

Saturday 17 December 2011

Lansoprazol Farmindustria




Lansoprazol Farmindustria may be available in the countries listed below.


Ingredient matches for Lansoprazol Farmindustria



Lansoprazole

Lansoprazole is reported as an ingredient of Lansoprazol Farmindustria in the following countries:


  • Peru

International Drug Name Search

Monday 12 December 2011

NitroMist




In the US, NitroMist (nitroglycerin systemic) is a member of the following drug classes: antianginal agents, vasodilators and is used to treat Angina, Angina Pectoris Prophylaxis, Heart Attack, Heart Failure and High Blood Pressure.

US matches:

  • NitroMist

  • Nitromist oral/sublingual

Ingredient matches for NitroMist



Nitroglycerin

Nitroglycerin is reported as an ingredient of NitroMist in the following countries:


  • United States

International Drug Name Search

Friday 9 December 2011

Sayana




Sayana may be available in the countries listed below.


Ingredient matches for Sayana



Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Sayana in the following countries:


  • Austria

  • Germany

International Drug Name Search

Tuesday 6 December 2011

Pipamperone Hydrochloride




Pipamperone Hydrochloride may be available in the countries listed below.


Ingredient matches for Pipamperone Hydrochloride



Pipamperone

Pipamperone Hydrochloride (JAN) is also known as Pipamperone (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ketavet




Ketavet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ketavet



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Ketavet in the following countries:


  • Australia

  • Germany

  • Italy

International Drug Name Search

Saturday 26 November 2011

Norvectan




Norvectan may be available in the countries listed below.


Ingredient matches for Norvectan



Ibuprofen

Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Norvectan in the following countries:


  • Spain

International Drug Name Search

Wednesday 23 November 2011

Glinid




Glinid may be available in the countries listed below.


Ingredient matches for Glinid



Glibenclamide

Glibenclamide is reported as an ingredient of Glinid in the following countries:


  • Peru

International Drug Name Search

Tuesday 22 November 2011

Venlectine




Venlectine may be available in the countries listed below.


Ingredient matches for Venlectine



Venlafaxine

Venlafaxine is reported as an ingredient of Venlectine in the following countries:


  • Poland

International Drug Name Search

Monday 21 November 2011

Tilidin Hexal comp




Tilidin Hexal comp may be available in the countries listed below.


Ingredient matches for Tilidin Hexal comp



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Tilidin Hexal comp in the following countries:


  • Germany

Tilidine

Tilidine hydrochloride hemihydrate (a derivative of Tilidine) is reported as an ingredient of Tilidin Hexal comp in the following countries:


  • Germany

International Drug Name Search

Thursday 17 November 2011

Norfacin




Norfacin may be available in the countries listed below.


Ingredient matches for Norfacin



Norfloxacin

Norfloxacin is reported as an ingredient of Norfacin in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday 9 November 2011

Halothane




In some countries, this medicine may only be approved for veterinary use.


In the US, Halothane (halothane systemic) is a member of the drug class general anesthetics.

US matches:

  • Halothane

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01AB01

CAS registry number (Chemical Abstracts Service)

0000151-67-7

Chemical Formula

C2-H-Br-Cl-F3

Molecular Weight

197

Therapeutic Category

Anesthetic, inhalation

Chemical Name

Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-

Foreign Names

  • Halothanum (Latin)
  • Halothan (German)
  • Halothane (French)
  • Halotano (Spanish)

Generic Names

  • Alotano (OS: DCIT)
  • Halothane (OS: JAN, DCF, BAN)
  • Phthorothanum (IS)
  • Halothan (PH: Ph. Eur. 6)
  • Halothane (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XIV)
  • Halothanum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Anestane
    Hikma, United Arab Emirates; Hikma, Egypt; Hikma, Iraq; Hikma, Jordan; Hikma, Kuwait; Hikma, Lebanon; Hikma, Libya; Hikma, Oman; Hikma, Qatar; Hikma, Saudi Arabia; Hikma, Sudan; Hikma, Syria; Hikma, Tunisia; Hikma, Yemen


  • Fluothane
    AstraZeneca, United Arab Emirates; AstraZeneca, Bangladesh; AstraZeneca, Bahrain; AstraZeneca, Brazil; AstraZeneca, Cyprus; AstraZeneca, Egypt; AstraZeneca, Ethiopia; AstraZeneca, Ghana; AstraZeneca, Israel; AstraZeneca, Iraq; AstraZeneca, Jordan; AstraZeneca, Kenya; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Libya; AstraZeneca, Malawi; AstraZeneca, Mozambique; AstraZeneca, Nigeria; AstraZeneca, Qatar; AstraZeneca, Saudi Arabia; AstraZeneca, Sudan; AstraZeneca, Syria; AstraZeneca, Turkey; AstraZeneca, Tanzania; AstraZeneca, Uganda; AstraZeneca, Yemen; AstraZeneca, Zambia; AstraZeneca, Zimbabwe; Nicholas, India; Takeda, Japan


  • Fluothane (veterinary use)
    Fort Dodge Animale Health, United States; Schering-Plough Veterinary, United Kingdom


  • Halosin
    ACI, Bangladesh


  • Halotane
    Rhodia, Romania


  • Halotano
    Behrens, Venezuela; Bestpharma, Chile; Cristalia, Peru; Lafedar, Argentina; Pharmaceutical, Venezuela; Rivero, Argentina


  • Halothaan (veterinary use)
    Ceva, Netherlands


  • Halothan
    Jugoremedija, Serbia


  • Halothane "Hoechst"
    Hoechst, Ethiopia


  • Halothane Belamont
    CSP, France


  • Halothane M&B
    Dexa Medica, Indonesia


  • Halothane Vet (veterinary use)
    Fort Dodge Animale Health, United States; Halocarbon, United States; Merial, United Kingdom; Merial, Ireland; Merial, Italy; Merial Ancare, New Zealand; Pharmachem, Australia


  • Halothane
    Promedico, Israel; Rhodia, Israel; Unimed & Unihealth, Bangladesh


  • Halothano
    Rhodia, Argentina


  • Ineltano
    Richmond, Argentina


  • Narcotan
    Zentiva, Czech Republic; Zentiva, Georgia; Zentiva, Latvia; Zentiva, Poland; Zentiva, Romania; Zentiva, Slovakia


  • Vetothane (veterinary use)
    Virbac, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 1 November 2011

Baci




Ingredient matches for Baci



Bacitracin

Bacitracin is reported as an ingredient of Baci in the following countries:


  • United States

International Drug Name Search

Friday 28 October 2011

Seronil




Seronil may be available in the countries listed below.


Ingredient matches for Seronil



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Seronil in the following countries:


  • Finland

  • Poland

International Drug Name Search

Wednesday 26 October 2011

Propofol Kabi




Propofol Kabi may be available in the countries listed below.


Ingredient matches for Propofol Kabi



Propofol

Propofol is reported as an ingredient of Propofol Kabi in the following countries:


  • Italy

International Drug Name Search

Sunday 23 October 2011

Elmifarma




Elmifarma may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Elmifarma



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Elmifarma in the following countries:


  • Italy

International Drug Name Search

Thursday 20 October 2011

Pen-A




Pen-A may be available in the countries listed below.


Ingredient matches for Pen-A



Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Pen-A in the following countries:


  • Bangladesh

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Pen-A in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday 19 October 2011

Neostigmin DeltaSelect




Neostigmin DeltaSelect may be available in the countries listed below.


Ingredient matches for Neostigmin DeltaSelect



Neostigmine

Neostigmine metilsulfate (a derivative of Neostigmine) is reported as an ingredient of Neostigmin DeltaSelect in the following countries:


  • Germany

International Drug Name Search

Tuesday 18 October 2011

Altosone




Altosone may be available in the countries listed below.


Ingredient matches for Altosone



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Altosone in the following countries:


  • Italy

International Drug Name Search

Sunday 16 October 2011

Doctors Foster and Smith Benzocaine Liquid





Dosage Form: FOR ANIMAL USE ONLY

Drs. Foster and Smith CutStop styptic pads have been specially formulated as an aid in the control of minor bleeding. CutStop will also serve to temporarily relieve pain caused by clipping nails or small wounds.



DIRECTIONS FOR USE


Apply pad directly to bleeding area with slight pressure. If bleeding persists, or in the case of a puncture wound, consult a veterinarian immediately.



ACTIVE INGREDIENT


0.2% Benzocaine



OTHER INGREDIENTS


Water, Ferric Subsulfate, Isopropyl Alcohol, Benzalkonium Chloride.



Item#1086


For questions or to reorder:


1-800-562-7169


www.DrsFosterSmith.com



Keep out of reach of children and pets to avoid unwanted consumption



Doctors Foster and Smith


CUTSTOP


Ready - to -Use


Styptic pads


Stops bleeding


from clipped nails


or small wounds


90 Pads










DOCTORS FOSTER AND SMITH 
benzocaine  liquid










Product Information
Product TypeOTC ANIMAL DRUGNDC Product Code (Source)65713-911
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (BENZOCAINE)BENZOCAINE0.207 g  in 103.6 g












Inactive Ingredients
Ingredient NameStrength
WATER 
FERRIC SULFATE 
ISOPROPYL ALCOHOL 
BENZALKONIUM CHLORIDE 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
165713-911-05103.6 g In 1 JARNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2001


Labeler - Doctors Foster and Smith (122135148)

Registrant - United Pet Group (931135730)









Establishment
NameAddressID/FEIOperations
JUNGLE LABORATORIES CORPORATION032615270manufacture
Revised: 02/2010Doctors Foster and Smith



Friday 14 October 2011

Polcrom




Polcrom may be available in the countries listed below.


Ingredient matches for Polcrom



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Polcrom in the following countries:


  • Poland

International Drug Name Search

Tuesday 11 October 2011

buprenorphine transdermal



Generic Name: buprenorphine (transdermal) (BUE pre NOR feen)

Brand Names: Butrans


What is this drug?

Buprenorphine is a narcotic (opioid) pain medicine.


Buprenorphine transdermal (skin patch) is used to treat moderate to severe chronic pain when treatment is needed around the clock.


Buprenorphine is not for treating pain just after surgery, or for treating occasional short-term pain.

Buprenorphine transdermal may also be used for purposes not listed in this medication guide.


What is the most important information I should know about this drug?


You should not use buprenorphine if you are allergic to it, or if you have a severe breathing disorder such as asthma, or a bowel obstruction called paralytic ileus.

Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.


Do not expose the skin patch to heat while you are wearing it. Heat can increase the amount of drug you absorb through your skin and may cause harmful effects.

Call your doctor at once if you have weak or shallow breathing, snoring that is new or unusual, slow heart rate, confusion, severe dizziness, seizure, or feeling like you might pass out.


Avoid letting another person handle your buprenorphine skin patches. Keep both used and unused patches out of the reach of children or pets. The amount of buprenorphine in a used skin patch could be fatal to a child or pet who accidentally sucks or chews on it. Seek emergency medical attention if this happens. Do not stop using buprenorphine suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using buprenorphine.

What should I discuss with my health care provider before using this drug?


You should not use buprenorphine if you are allergic to it, or if you have:

  • asthma or severe breathing disorder; or




  • a bowel obstruction called paralytic ileus.




Do not use buprenorphine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. Serious, life threatening side effects can occur if you use buprenorphine before the MAO inhibitor has cleared from your body.

To make sure you can safely use buprenorphine, tell your doctor if you have any of these other conditions:



  • COPD (chronic obstructive pulmonary disease), sleep apnea, or other breathing disorders;




  • a personal or family history of "Long QT syndrome":




  • hepatitis B or C;




  • liver or kidney disease;




  • a thyroid disorder;




  • gallbladder disease;




  • curvature of the spine;




  • a history of head injury or brain tumor;




  • epilepsy or other seizure disorder;




  • low blood pressure;




  • Addison's disease or other adrenal gland disorders;




  • enlarged prostate, urination problems;




  • depression or other mental illness; or




  • a history of drug or alcohol addiction.




Buprenorphine may be habit-forming and should be used only by the person it was prescribed for. Never share buprenorphine with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it. FDA pregnancy category C. It is not known whether buprenorphine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Buprenorphine can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using buprenorphine.

Your dose needs may be different if you have recently used an opioid pain medicine and your body is tolerant to it. Opioids include Tylenol #3, Lortab, Vicodin, OxyContin, Percocet, Darvocet, Actiq, morphine, and many others. Talk with your doctor if you are not sure you are opioid-tolerant.


How should I use this drug?


Use exactly as prescribed. Never use buprenorphine in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.


This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


If you are switching to buprenorphine transdermal from another narcotic pain medicine, you may need to slowly stop using the other medicine. Follow your doctor's instructions.


Apply the skin patch only to clean, dry skin. Use only clear water to wash the skin before you apply a skin patch. Soaps or other chemicals could increase the amount of buprenorphine your skin absorbs.


Apply the patch to a flat and hairless area of the chest, back, side, or outer side of your upper arm. Wear the patch around the clock for 7 days. Never wear more than 1 buprenorphine skin patch at a time unless your doctor has told you to.


Do not use soaps or other chemicals could increase the amount of buprenorphine your skin absorbs.

Do not use a buprenorphine transdermal skin patch if it has been cut or damaged.


After removing a skin patch fold it in half, sticky side in, and flush the patch down the toilet or use the Patch-Disposal Unit provided with this medication. Apply a new patch to a different skin area on the chest, back, side, or upper arm. Do not use the same skin area twice in a row.


Never share this medication with another person, even if they have the same symptoms you have. Ask your doctor how to avoid withdrawal symptoms when you stop using buprenorphine. Keep both used and unused buprenorphine skin patches out of the reach of children or pets. The amount of buprenorphine in a used skin patch could be fatal to a child or pet who accidentally sucks or chews on the patch. Seek emergency medical attention if this happens.

Keep track of how many skin patches have been used from each new package of this medicine. Buprenorphine is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.


Store at room temperature. Keep each patch in its foil pouch until you are ready to use it.

What happens if I miss a dose?


If you forget to change a patch on your scheduled day, remove the patch and apply a new one as soon as you remember. Do not wear extra patches to make up a missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. The amount of buprenorphine in a used or unused skin patch can be fatal to a child who accidentally sucks or chews on the patch.

Overdose symptoms may include extreme drowsiness, weak or limp feeling, weak pulse, cold and clammy skin, fainting, shallow breathing, snoring, or breathing that stops.


What should I avoid while using this drug?


Do not drink alcohol or you may have serious, life-threatening side effects. Buprenorphine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Avoid getting up too fast from a sitting or lying position, or you may feel dizzy. Get up slowly and steady yourself to prevent a fall. Do not expose the skin patch to heat while you are wearing it. This includes a hot tub, heating pad, electric blanket, sauna, heated water bed, or a hot bath. Avoid exposure to sunlight or tanning beds. Heat can increase the amount of drug you absorb through your skin and may cause harmful effects. Avoid letting another person handle your buprenorphine skin patches. If the sticky side of a skin patch comes into contact with another person, wash the skin with clear water and seek medical care at once.

This drug side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using buprenorphine and call your doctor at once if you have a serious side effect such as:

  • slow heart rate, weak or shallow breathing, deep sighs, snoring that is new or unusual;




  • confusion, severe dizziness, feeling like you might pass out;




  • blisters, swelling, or severe irritation where the patch was worn;




  • seizure (convulsions); or




  • nausea, upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • headache;




  • vomiting, dry mouth, upset stomach, constipation;




  • mild dizziness or drowsiness; or




  • redness, itching, or mild skin rash where the patch was worn.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Buprenorphine Dosing Information


Usual Adult Dose for Opiate Dependence:

Initial dose: 8 mg sublingually on day 1.
Maintenance dose: Rapidly titrate to the recommended target dose of 16 mg/day. In clinical trials, patients received 8 mg on day 1 and 16 mg on day 2 and thereafter. Further dose adjustments may be made in 2 mg to 4 mg increments up to a level that suppresses opioid withdrawal symptoms and holds the patient in treatment. The usual daily range is 4 mg to 24 mg sublingually.

The tablets should be placed under the tongue at the same time and allowed to dissolve. If patients are taking more than 2 tablets per dose and cannot hold more than 2 under the tongue comfortably, they should use 2 tablets at a time, allowing them to dissolve completely before taking more tablets.

For patients taking heroin or short-acting opioids, the first dose should be administered at least 4 hours after the patient last used opioids or preferably when early withdrawal symptoms appear.

Withdrawal symptoms may occur during buprenorphine induction treatment of patients taking methadone or long-acting opioids, especially high opioid doses or when buprenorphine is administered shortly after the last opioid dose. The optimal time for the first dose has not been reported.

The optimal method of tapering to discontinuation has not been reported.

Usual Adult Dose for Pain:

IM or IV:
Initial: 0.3 mg slow IM or IV every 6 hours as needed. May repeat once 30 to 60 minutes after the initial dose. Maximum single dose: 0.6 mg (IM only)

Transdermal patches: Apply 1 patch to a hairless or nearly hairless intact skin site. There are 8 possible application sites: upper outer arm, upper chest, upper back, and side of the chest (on both sides of the body). The patch is worn for 7 days. Maximum dose: 20 mcg/hour

Usual Pediatric Dose for Pain:

Less than 2 years: Safety and effectiveness have not been established.
2 to 12 years: 2 to 6 mcg/kg IM or slow IV every 4 to 6 hours.
13 to 18 years: 0.3 mg IM or slow IV every 6 hours; may repeat dose in 30 to 60 minutes.


What other drugs will affect this drug?


Tell your doctor if you regularly use other medicines that can make you sleepy or slow your breathing (such as cold or allergy medicine, sedatives, anti-nausea medicine, other narcotic pain medicines, sleeping pills, muscle relaxers, heart rhythm medications, and medicine for seizures, depression, or anxiety). They can add to the side effects of buprenorphine and dangerous side effects may result.

  • dexamethasone (Decadron, Hexadrol);




  • St. John's wort;




  • rifabutin (Mycobutin), rifampin (Rifadin, Rifater, Rifamate), or rifapentine (Priftin);




  • phenobarbital (Solfoton) or other barbiturates;




  • diazepam (Valium) or similar medicines such as alprazolam (Xanax), lorazepam (Ativan), clorazepate (Tranxene), and others;




  • a heart rhythm medication such as amiodarone (Cordarone, Pacerone), disopyramide (Norpace), dofetilide (Tikosyn), flecaininde (Tambocor), procainamide (Pronestyl), propafenone, (Rythmol), quinidine (Quin-G), sotalol (Betapace), and others;




  • HIV medication such as efavirenz (Sustiva), etravirine (Intelence), nevirapine (Viramune), or ritonavir (Kaletra, Norvir); or




  • seizure medication such as carbamazepine (Carbatrol, Tegretol), felbamate (Felbatol), oxcarbazepine (Trileptal), phenytoin (Dilantin), or primidone (Mysoline).



This list is not complete and other drugs may interact with buprenorphine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More buprenorphine resources


  • Buprenorphine Side Effects (in more detail)
  • Buprenorphine Dosage
  • Buprenorphine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Buprenorphine Drug Interactions
  • Buprenorphine Support Group
  • 84 Reviews for Buprenorphine - Add your own review/rating


Compare buprenorphine with other medications


  • Opiate Dependence
  • Pain


Where can I get more information?


  • Your pharmacist can provide more information about buprenorphine.

See also: buprenorphine side effects (in more detail)


Friday 30 September 2011

Propoxyphene Hydrochloride




Ingredient matches for Propoxyphene Hydrochloride



Dextropropoxyphene

Propoxyphene Hydrochloride (USAN) is also known as Dextropropoxyphene (Rec.INN)

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 28 September 2011

Bactamox




Bactamox may be available in the countries listed below.


Ingredient matches for Bactamox



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Bactamox in the following countries:


  • Bangladesh

International Drug Name Search

Friday 23 September 2011

Paradrops




Paradrops may be available in the countries listed below.


Ingredient matches for Paradrops



Paracetamol

Paracetamol is reported as an ingredient of Paradrops in the following countries:


  • Iceland

International Drug Name Search

Thursday 22 September 2011

Pindolol




In the US, Pindolol (pindolol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat High Blood Pressure.

US matches:

  • Pindolol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AA03

CAS registry number (Chemical Abstracts Service)

0013523-86-9

Chemical Formula

C14-H20-N2-O2

Molecular Weight

248

Therapeutic Categories

ß-Adrenergic blocking agent

Glaucoma treatment

Chemical Name

2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-

Foreign Names

  • Pindololum (Latin)
  • Pindolol (German)
  • Pindolol (French)
  • Pindolol (Spanish)

Generic Names

  • Pindolol (OS: BAN, USAN, JAN, DCF)
  • Pindololo (OS: DCIT)
  • LB-46 (IS)
  • Pindolol (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
  • Pindololum (PH: Ph. Eur. 6)

Brand Names

  • Apo-Pindol
    Apotex, Canada


  • Barbloc
    Alphapharm, Australia; Alphapharm, Taiwan


  • Barusamizin
    Taiyo Pharmaceutical, Japan


  • Blocklin-L
    Shionogi Seiyaku, Japan


  • Cardilate
    ASKA SeiyakuAsuka, Japan


  • Carpilol
    Choseido Pharmaceutical, Japan


  • Carvisken
    Alfresa Pharma Corporation, Japan


  • Casimten R
    Zensei Yakuhin, Japan


  • Gen-Pindolol
    Genpharm, Canada


  • Glauco-Stulln
    Stulln, Germany


  • Glutalan R
    Nihon Yakuhin Kogyo, Japan


  • Hexapindol
    Sandoz, Denmark


  • Isuhart
    Takata Seiyaku, Japan


  • Keiviskene
    Sankei Yakuhin, Japan


  • Let Lit
    Kotobuki Seiyaku, Japan


  • Nu-Pindol
    Nu-Pharm, Canada


  • Osnon
    Tatsumi Kagaku, Japan


  • Pinden
    Unipharm, Israel


  • Pindocor
    Merck NM, Finland


  • Pindol
    Pacific, New Zealand


  • Pindoloc R
    Daito, Japan


  • Pindolol CF
    Centrafarm, Netherlands


  • Pindolol Mylan
    Mylan, Sweden


  • Pindolol Ohara
    Ohara Yakuhin, Japan


  • Pindolol PCH
    Pharmachemie, Netherlands


  • Pindolol ratiopharm
    ratiopharm, Netherlands


  • Pindolol Towa
    Towa Yakuhin, Japan


  • Pindolol
    Genpharm, United States; Mylan, United States; Sandoz, United States; URL, United States; Watson, United States


  • Pindolol F
    Teikoku Medix, Japan


  • Pindolol
    N Nichi-Iko PharmaceuticalJMA, Japan


  • Pinloc
    Orion, Finland


  • Pithiorol
    Tsuruhara Seiyaku, Japan


  • Sandoz Pindolol
    Sandoz, Canada


  • Tenzimet (Pindolol and Clopamide)
    Krka, Slovenia


  • Viringal
    Isei, Japan


  • Viskaldix (Pindolol and Clopamide)
    Amdipharm, United Kingdom; Egis, Hungary; Novartis, Belgium; Novartis, Switzerland; Novartis, Germany; Novartis, France; Novartis, Ireland


  • Viskeen
    Novartis, Netherlands


  • Visken
    Amdipharm, United Kingdom; Egis, Hungary; Egis, Russian Federation; Novartis, Austria; Novartis, Australia; Novartis, Belgium; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Germany; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Ghana; Novartis, Greece; Novartis, Hong Kong; Novartis, Ireland; Novartis, India; Novartis, Iceland; Novartis, Kenya; Novartis, Luxembourg; Novartis, Libya; Novartis, Nigeria; Novartis, Philippines; Novartis, Poland; Novartis, Sudan; Novartis, Turkey; Novartis, Tanzania; Novartis, Zimbabwe; Teofarma, Italy


  • Viskén
    Novartis, Sweden; Novartis, Tunisia


  • Youvisken
    Yoshindo, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 21 September 2011

Relapan




Relapan may be available in the countries listed below.


Ingredient matches for Relapan



Scopolamine

Scopolamine is reported as an ingredient of Relapan in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday 13 September 2011

Pralifan




Pralifan may be available in the countries listed below.


Ingredient matches for Pralifan



Mitoxantrone

Mitoxantrone dihydrochloride (a derivative of Mitoxantrone) is reported as an ingredient of Pralifan in the following countries:


  • Spain

International Drug Name Search

Monday 12 September 2011

Gabapentin Winthrop




Gabapentin Winthrop may be available in the countries listed below.


Ingredient matches for Gabapentin Winthrop



Gabapentin

Gabapentin is reported as an ingredient of Gabapentin Winthrop in the following countries:


  • Italy

International Drug Name Search

Saturday 10 September 2011

Aromag




Aromag may be available in the countries listed below.


Ingredient matches for Aromag



Magnesium Carbonate

Magnesium Carbonate light (a derivative of Magnesium Carbonate) is reported as an ingredient of Aromag in the following countries:


  • Singapore

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Aromag in the following countries:


  • Singapore

International Drug Name Search

Friday 9 September 2011

Venlax




Venlax may be available in the countries listed below.


Ingredient matches for Venlax



Venlafaxine

Venlafaxine is reported as an ingredient of Venlax in the following countries:


  • Poland

International Drug Name Search

Thursday 25 August 2011

Bestrner




Bestrner may be available in the countries listed below.


Ingredient matches for Bestrner



Beraprost

Beraprost sodium (a derivative of Beraprost) is reported as an ingredient of Bestrner in the following countries:


  • Japan

International Drug Name Search

Wednesday 24 August 2011

Selegilin-ratiopharm




Selegilin-ratiopharm may be available in the countries listed below.


Ingredient matches for Selegilin-ratiopharm



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Selegilin-ratiopharm in the following countries:


  • Czech Republic

  • Germany

International Drug Name Search

Sunday 21 August 2011

Biotine Bayer




Biotine Bayer may be available in the countries listed below.


Ingredient matches for Biotine Bayer



Biotin

Biotin is reported as an ingredient of Biotine Bayer in the following countries:


  • France

International Drug Name Search

Saturday 20 August 2011

Enkacort




Enkacort may be available in the countries listed below.


Ingredient matches for Enkacort



Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Enkacort in the following countries:


  • Indonesia

International Drug Name Search

Friday 19 August 2011

Acuprel




Acuprel may be available in the countries listed below.


Ingredient matches for Acuprel



Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Acuprel in the following countries:


  • Spain

International Drug Name Search

Wednesday 17 August 2011

Prialt


Prialt is a brand name of ziconotide, approved by the FDA in the following formulation(s):


PRIALT (ziconotide acetate - injectable; intrathecal)



  • Manufacturer: AZUR PHARMA II

    Approval date: December 28, 2004

    Strength(s): 100MCG/1ML (100MCG/ML) [RLD], 500MCG/20ML (25MCG/ML) [RLD], 500MCG/5ML (100MCG/ML) [RLD]

Has a generic version of Prialt been approved?


No. There is currently no therapeutically equivalent version of Prialt available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prialt. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method of producing analgesia
    Patent 5,364,842
    Issued: November 15, 1994
    Inventor(s): Justice; Alan & Singh; Tejinder & Gohil; Kishor C. & Valentino; Karen L.
    Assignee(s): Neurex Corporation
    A method of producing analgesia and enhancing opiate analgesia is disclosed. The method includes administering TVIA (SNX-185) or MVIIA (SNX-111) omega-conopeptide, or derivative thereof which is characterized by its ability to (a) inhibit voltage-gated calcium channels selectively in neuronal tissue, as evidenced by the peptide's ability to inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind to omega-conopeptide MVIIA binding sites present in neuronal tissue.
    Patent expiration dates:

    • December 30, 2016
      ✓ 
      Patent use: TREATMENT OF PAIN


    • December 30, 2016
      ✓ 
      Patent use: ANALGESIA




  • Stable omega conopetide formulations
    Patent 5,795,864
    Issued: August 18, 1998
    Inventor(s): Amstutz; Gary Arthur & Bowersox; Stephen Scott & Gohil; Kishorchandra & Adriaenssens; Peter Isadore & Kristipati; Ramasharma
    Assignee(s): Neurex Corporation
    Disclosed are formulations effective to stabilize omega conotoxin peptide preparations at elevated temperatures. Novel omega conopeptides also form part of the invention.
    Patent expiration dates:

    • June 27, 2015
      ✓ 
      Drug product




  • Methods for producing analgesia
    Patent 5,859,186
    Issued: January 12, 1999
    Inventor(s): Justice; Alan & Singh; Tejinder & Gohil; Kishor Chandra & Valentino; Karen L. & Miljanich; George P.
    Assignee(s): Neurex Corporation
    A method of producing analgesia in nociceptive and neuropathic pain is disclosed. The method includes administering to a subject an omega conopeptide which is characterized by its ability to (a) inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind selectively to omega conopeptide MVIIA binding sites present in neuronal tissue. Also disclosed are novel omega conotoxin peptides effective in producing analgesia.
    Patent expiration dates:

    • December 30, 2011
      ✓ 
      Patent use: ANALGESIA


    • December 30, 2011
      ✓ 
      Patent use: TREATMENT OF PAIN



See also...

  • Prialt Consumer Information (Drugs.com)
  • Prialt Consumer Information (Wolters Kluwer)
  • Prialt Consumer Information (Cerner Multum)
  • Prialt Advanced Consumer Information (Micromedex)
  • Prialt AHFS DI Monographs (ASHP)
  • Ziconotide Consumer Information (Drugs.com)
  • Ziconotide Consumer Information (Wolters Kluwer)
  • Ziconotide Consumer Information (Cerner Multum)
  • Ziconotide Intrathecal Advanced Consumer Information (Micromedex)
  • Ziconotide AHFS DI Monographs (ASHP)

Saturday 13 August 2011

Relyovix




Relyovix may be available in the countries listed below.


Ingredient matches for Relyovix



Cefatrizine

Cefatrizine comp. with propylene glycole (a derivative of Cefatrizine) is reported as an ingredient of Relyovix in the following countries:


  • Greece

International Drug Name Search

Thursday 11 August 2011

Erycreat




Erycreat may be available in the countries listed below.


Ingredient matches for Erycreat



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erycreat in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Wednesday 10 August 2011

Alercas




Alercas may be available in the countries listed below.


Ingredient matches for Alercas



Fexofenadine

Fexofenadine hydrochloride (a derivative of Fexofenadine) is reported as an ingredient of Alercas in the following countries:


  • Argentina

International Drug Name Search

Sunday 7 August 2011

Amenflox




Amenflox may be available in the countries listed below.


Ingredient matches for Amenflox



Gatifloxacin

Gatifloxacin is reported as an ingredient of Amenflox in the following countries:


  • Vietnam

International Drug Name Search

Tuesday 2 August 2011

Cusi Gentamcyin




Cusi Gentamcyin may be available in the countries listed below.


Ingredient matches for Cusi Gentamcyin



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Cusi Gentamcyin in the following countries:


  • Oman

International Drug Name Search

Tuesday 26 July 2011

Pentazocinum




Pentazocinum may be available in the countries listed below.


Ingredient matches for Pentazocinum



Pentazocine

Pentazocine is reported as an ingredient of Pentazocinum in the following countries:


  • Poland

International Drug Name Search

Friday 22 July 2011

Cloranxen




Cloranxen may be available in the countries listed below.


Ingredient matches for Cloranxen



Dipotassium Clorazepate

Dipotassium Clorazepate is reported as an ingredient of Cloranxen in the following countries:


  • Poland

International Drug Name Search

Tuesday 19 July 2011

Sidevar




Sidevar may be available in the countries listed below.


Ingredient matches for Sidevar



Lovastatin

Lovastatin is reported as an ingredient of Sidevar in the following countries:


  • Mexico

International Drug Name Search

Monday 18 July 2011

Paroxetina Allen




Paroxetina Allen may be available in the countries listed below.


Ingredient matches for Paroxetina Allen



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Allen in the following countries:


  • Italy

International Drug Name Search

Sunday 17 July 2011

Fintop




Fintop may be available in the countries listed below.


Ingredient matches for Fintop



Butenafine

Butenafine hydrochloride (a derivative of Butenafine) is reported as an ingredient of Fintop in the following countries:


  • India

  • Oman

International Drug Name Search

Saturday 16 July 2011

Cetirizin-ratiopharm




Cetirizin-ratiopharm may be available in the countries listed below.


Ingredient matches for Cetirizin-ratiopharm



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizin-ratiopharm in the following countries:


  • Austria

  • Denmark

  • Germany

  • Hungary

International Drug Name Search

Fluoxetine Generics




Fluoxetine Generics may be available in the countries listed below.


Ingredient matches for Fluoxetine Generics



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetine Generics in the following countries:


  • Greece

International Drug Name Search

Frimaind




Frimaind may be available in the countries listed below.


Ingredient matches for Frimaind



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Frimaind in the following countries:


  • Italy

International Drug Name Search

Tuesday 5 July 2011

Loratadin Actavis




Loratadin Actavis may be available in the countries listed below.


Ingredient matches for Loratadin Actavis



Loratadine

Loratadine is reported as an ingredient of Loratadin Actavis in the following countries:


  • Denmark

  • Sweden

  • Switzerland

International Drug Name Search

Selegiline HCl Sandoz




Selegiline HCl Sandoz may be available in the countries listed below.


Ingredient matches for Selegiline HCl Sandoz



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Selegiline HCl Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Friday 1 July 2011

Premelle




Premelle may be available in the countries listed below.


Ingredient matches for Premelle



Conjugated Estrogens

Estrogens, conjugated is reported as an ingredient of Premelle in the following countries:


  • Oman

  • South Africa

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Premelle in the following countries:


  • Oman

  • South Africa

International Drug Name Search

Pertussis Medications


Definition of Pertussis:

Pertussis is a highly contagious bacterial disease that causes uncontrollable, violent coughing. The coughing can make it hard to breathe. A deep "whooping" sound is often heard when the patient tries to take a breath.

Drugs associated with Pertussis

The following drugs and medications are in some way related to, or used in the treatment of Pertussis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Pertussis

  • Pertussis Prophylaxis (9 drugs)

Learn more about Pertussis





Drug List:

Monday 20 June 2011

Aflumicot




Aflumicot may be available in the countries listed below.


Ingredient matches for Aflumicot



Fluconazole

Fluconazole is reported as an ingredient of Aflumicot in the following countries:


  • Venezuela

International Drug Name Search

Thursday 16 June 2011

Thiocolchicoside G Gam




Thiocolchicoside G Gam may be available in the countries listed below.


Ingredient matches for Thiocolchicoside G Gam



Thiocolchicoside

Thiocolchicoside is reported as an ingredient of Thiocolchicoside G Gam in the following countries:


  • France

International Drug Name Search

Pandel


Pandel is a brand name of hydrocortisone topical, approved by the FDA in the following formulation(s):


PANDEL (hydrocortisone probutate - cream; topical)



  • Manufacturer: FOUGERA PHARMS

    Approval date: February 28, 1997

    Strength(s): 0.1% [RLD]

Has a generic version of Pandel been approved?


No. There is currently no therapeutically equivalent version of Pandel available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pandel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Pandel.

See also...

  • Pandel Consumer Information (Cerner Multum)
  • Pandel Topical application Advanced Consumer Information (Micromedex)
  • Hemorrhoidal-HC Suppositories Consumer Information (Wolters Kluwer)
  • Hydrocortisone Acetate Suppositories Consumer Information (Wolters Kluwer)
  • Hydrocortisone Butyrate Solution Consumer Information (Wolters Kluwer)
  • Hydrocortisone Cream Consumer Information (Wolters Kluwer)
  • Hydrocortisone Foam Consumer Information (Wolters Kluwer)
  • Hydrocortisone Gel Consumer Information (Wolters Kluwer)
  • Hydrocortisone Lotion Consumer Information (Wolters Kluwer)
  • Hydrocortisone rectal cream, ointment, suppository Consumer Information (Cerner Multum)
  • Hydrocortisone topical Consumer Information (Cerner Multum)
  • Anusol HC Advanced Consumer Information (Micromedex)
  • Barriere-Hc Topical application Advanced Consumer Information (Micromedex)
  • Cort-Eze Topical application Advanced Consumer Information (Micromedex)
  • Corta-Cap Advanced Consumer Information (Micromedex)
  • Cortagel Extra Strength Advanced Consumer Information (Micromedex)
  • Cortate Topical application Advanced Consumer Information (Micromedex)
  • Corticool Maximum Strength Advanced Consumer Information (Micromedex)
  • Cortoderm Mild Ointment Topical application Advanced Consumer Information (Micromedex)
  • Cortoderm Regular Ointment Topical application Advanced Consumer Information (Micromedex)
  • Delacort Advanced Consumer Information (Micromedex)
  • Dermarest Advanced Consumer Information (Micromedex)
  • Emo-Cort Scalp Solution Topical application Advanced Consumer Information (Micromedex)
  • Emo-Cort Topical application Advanced Consumer Information (Micromedex)
  • Foille Cort Advanced Consumer Information (Micromedex)
  • Hydrocortisone Cream Topical application Advanced Consumer Information (Micromedex)
  • Hydroval Advanced Consumer Information (Micromedex)
  • Hydrozone Plus Advanced Consumer Information (Micromedex)
  • Instacort-10 Advanced Consumer Information (Micromedex)
  • Ivy Soothe Advanced Consumer Information (Micromedex)
  • IvyStat Advanced Consumer Information (Micromedex)
  • Keratol HC Advanced Consumer Information (Micromedex)
  • Kericort 10 Advanced Consumer Information (Micromedex)
  • Medi-Cortisone Maximum Strength Advanced Consumer Information (Micromedex)
  • Microcort Advanced Consumer Information (Micromedex)
  • Mycin Scalp Advanced Consumer Information (Micromedex)
  • Neutrogena T/Scalp Advanced Consumer Information (Micromedex)
  • Novo-Hydrocort Cream Topical application Advanced Consumer Information (Micromedex)
  • Novo-Hydrocort Topical application Advanced Consumer Information (Micromedex)
  • NuCort Advanced Consumer Information (Micromedex)
  • Nupercainal HC Advanced Consumer Information (Micromedex)
  • Pediaderm HC Kit Advanced Consumer Information (Micromedex)
  • Prevex Hc Topical application Advanced Consumer Information (Micromedex)
  • Sarna Hc Topical application Advanced Consumer Information (Micromedex)
  • Sarnol-HC Maximum Strength Advanced Consumer Information (Micromedex)
  • Summer's Eve Specialcare Advanced Consumer Information (Micromedex)
  • Tarocort Advanced Consumer Information (Micromedex)
  • Therasoft Anti-Itch & Dermatitis Advanced Consumer Information (Micromedex)
  • Hydrocortisone Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone butyrate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone probutate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone valerate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone Acetate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Buteprate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Butyrate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Valerate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone topical AHFS DI Monographs (ASHP)

Tuesday 14 June 2011

Tasigna


Tasigna is a brand name of nilotinib, approved by the FDA in the following formulation(s):


TASIGNA (nilotinib hydrochloride monohydrate - capsule; oral)



  • Manufacturer: NOVARTIS

    Approval date: October 29, 2007

    Strength(s): EQ 200MG BASE [RLD]


  • Manufacturer: NOVARTIS

    Approval date: June 17, 2010

    Strength(s): EQ 150MG BASE

Has a generic version of Tasigna been approved?


No. There is currently no therapeutically equivalent version of Tasigna available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tasigna. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Inhibitors of tyrosine kinases
    Patent 7,169,791
    Issued: January 30, 2007
    Inventor(s): Breitenstein; Werner & Furet; Pascal & Jacob; Sandra & Manley; Paul William
    Assignee(s): Novartis AG
    The invention relates to compounds of formula wherein the substituents R1, R2 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease, in particular leukaemia, and a method for the treatment of such a disease.
    Patent expiration dates:

    • July 4, 2023
      ✓ 
      Patent use: A METHOD FOR THE TREATMENT OF LEUKEMIAS
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 29, 2012 - NEW CHEMICAL ENTITY

    • June 17, 2013 - TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE.

    • June 17, 2014 - TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE.

    • October 29, 2014 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Tasigna Consumer Information (Drugs.com)
  • Tasigna Consumer Information (Wolters Kluwer)
  • Tasigna Consumer Information (Cerner Multum)
  • Tasigna Advanced Consumer Information (Micromedex)
  • Tasigna AHFS DI Monographs (ASHP)
  • Nilotinib Consumer Information (Wolters Kluwer)
  • Nilotinib Consumer Information (Cerner Multum)
  • Nilotinib Advanced Consumer Information (Micromedex)
  • Nilotinib AHFS DI Monographs (ASHP)

Saturday 11 June 2011

Tobrasol




In the US, Tobrasol (tobramycin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis, Bacterial.

US matches:

  • Tobrasol

Ingredient matches for Tobrasol



Tobramycin

Tobramycin is reported as an ingredient of Tobrasol in the following countries:


  • Venezuela

International Drug Name Search

Thursday 9 June 2011

Potasyum Fosfat




Potasyum Fosfat may be available in the countries listed below.


Ingredient matches for Potasyum Fosfat



Potassium Citrate

Potassium Citrate is reported as an ingredient of Potasyum Fosfat in the following countries:


  • Turkey

International Drug Name Search

Fospropofol Disodium




Fospropofol Disodium may be available in the countries listed below.


Ingredient matches for Fospropofol Disodium



Fospropofol

Fospropofol Disodium (USAN) is known as Fospropofol in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 6 June 2011

Gascon




Gascon may be available in the countries listed below.


Ingredient matches for Gascon



Dimeticone

Dimeticone is reported as an ingredient of Gascon in the following countries:


  • China

  • Hong Kong

  • Japan

  • Taiwan

International Drug Name Search